Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "J05AG" (15)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Nevirapine (J05AG01) 8 products
WHO-DDD
DrugBank.ca
IP
CI
Viramune
30 Tablet(s)
180.75
211.90
20 %
Delayed release tablets: Nevirapinum 400 mg
Boehringer Ingelheim
(Schweiz) GmbH
A / SL / SO
FB
G
IP
CI
Viramune
14 Tablet(s)
29.73
48.75
10 %
Tablets: Nevirapinum 200 mg
Boehringer Ingelheim
(Schweiz) GmbH
A / SL / SO
FB
G
IP
CI
Viramune
60 Tablet(s)
127.44
155.00
10 %
Tablets: Nevirapinum 200 mg
Boehringer Ingelheim
(Schweiz) GmbH
A / SL / SO
FB
G
IP
CI
Nevirapin Viatris 400 mg
30
162.68
193.35
10 %
Delayed release tablets: Nevirapinum 400 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
IP
CI
Nevirapin-Mepha 400 mg
30
162.68
193.35
10 %
Delayed release tablets: Nevirapinum 400 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Nevirapin-Mepha 400 mg
30
k.A.
Delayed release tablets: Nevirapinum 400 mg
Mepha Pharma AG
A
FB
G
Nevirapin Sandoz 200 mg
14 Tablet(s)
k.A.
Sandoz
Pharmaceuticals AG
A
FB
G
Nevirapin Sandoz 200 mg
60 Tablet(s)
k.A.
Sandoz
Pharmaceuticals AG
A
FB
G
Efavirenz (J05AG03) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Efavirenz-Mepha 600 mg
30 Tablet(s)
211.41
246.35
10 %
Coated tablets: Efavirenzum 600 mg
Mepha Pharma AG
A / SL / SG
FB
G
Etravirine (J05AG04) 1 products
WHO-DDD
DrugBank.ca
L
SIP
IP
CI
Intelence 200 mg
60 Tablet(s)
335.75
381.55
10 %
Tablets: Etravirinum 200 mg
Janssen-Cilag AG
A / SL
FB
G
Rilpivirine (J05AG05) 4 products
WHO-DDD
DrugBank.ca
L
IP
CI
PP
Edurant
30 Tablet(s)
292.74
334.80
10 %
Coated tablets: Rilpivirinum 25 mg
Janssen-Cilag AG
A / SL
FB
G
L
IP
REKAMBYS 900 mg / 3 ml
487.92
547.05
10 %
Depot-Injektionssuspension: Rilpivirinum 900mg / 3ml
Janssen-Cilag AG
A / SL
FB
G
IP
REKAMBYS 600 mg / 2 ml
k.A.
Depot-Injektionssuspension: Rilpivirinum 600mg / 2ml
Janssen-Cilag AG
A
FB
G
IP
CI
Edurant 2.5 mg
90
k.A.
Tabletten zur Herstellung einer Suspension zum Einnehmen: Rilpivirinum 2.5 mg
Janssen-Cilag AG
A
FB
G
Doravirine (J05AG06) 1 products
WHO-DDD
L
IP
CI
Pifeltro
30
354.43
401.90
10 %
Coated tablets: Doravirinum 100 mg
MSD Merck Sharp &
Dohme AG
A / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
